Stock Events

Stock Events

Mineralys Therapeutics (MLYS) Q4 2024 Earnings

11NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-1.13

-0.96

-0.78

-0.61

Details

Expected EPS

-0.863333

Actual EPS

-1.13

Surprise EPS

-0.27

Surprise Percent

+30.89%

Description

Mineralys Therapeutics (MLYS) has reported earnings of -1.13 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.